Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.
about
A heparin binding synthetic peptide from human HIP / RPL29 fails to specifically differentiate between anticoagulantly active and inactive species of heparinHeparan sulfate 3-O-sulfation: a rare modification in search of a function.A synthetic heparan sulfate oligosaccharide library reveals the novel enzymatic action of D-glucosaminyl 3-O-sulfotransferase-3aHeparin-protein interactions.Protection of factor Xa from neutralization by the heparin-antithrombin complex.A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities.Evaluation of critical groups required for the binding of heparin to antithrombin.Circular dichroism spectroscopy of heparin-antithrombin interactionsEvidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparinStrategies in synthesis of heparin/heparan sulfate oligosaccharides: 2000-present.Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasmaStructure of the antithrombin-binding site in heparin.Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.Structure-function relationships of heparin species.Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose columnMicrobial heparin/heparan sulphate lyases: potential and applications.New Insights in Thrombin Inhibition Structure-Activity Relationships by Characterization of Octadecasaccharides from Low Molecular Weight Heparin.Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue.Heparin proteoglycans synthesized by mouse mastocytoma contain chondroitin sulphate.Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide.Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.Conformational transitions induced in heparin octasaccharides by binding with antithrombin III.Salmon antithrombin has only three carbohydrate side chains, and shows functional similarities to human beta-antithrombin.An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence.Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.Basement-membrane heparan sulphate with high affinity for antithrombin synthesized by normal and transformed mouse mammary epithelial cells.Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4Binding of platelet factor 4 to heparin oligosaccharides.The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.The molecular size of the antithrombin-binding sequence in heparin.Structure of heparin and heparin fragments.Chemically synthesized heparin-derived oligosaccharides.Role of endothelial cell surface heparin-like polysaccharides.A century of heparin: past, present and future.From Farm to Pharma: An Overview of Industrial Heparin Manufacturing Methods.Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.Relationship between anticoagulant activity of heparin and susceptibility to periodate oxidation.The mechanism by which serpins inhibit thrombin and other serine proteinases.Glycosaminoglycans and the regulation of blood coagulation.
P2860
Q21245645-07EA4128-64DE-4D72-8A9C-0C1AFB4E015BQ33690545-DEDCA98E-3104-403F-8672-CC737BD28952Q34083501-9AA0900C-A265-4192-883B-82107796A30DQ35030190-63B62DD9-6CBF-4D01-9E4B-2A7182A827ADQ35207027-05E0DE3E-D32F-4BF1-B191-6DB7CA5683D7Q36020898-16781490-0CB2-4F42-8310-9C146476E57EQ36248809-F1B6ECA6-D317-4C76-A0D7-27F9408794D7Q36322607-1F8A6DBE-D476-45AA-87D4-EE1DFBE05A89Q36414932-08EFDA2F-86C6-428E-BBA9-9F805AE768FDQ36822084-383FCE46-E14D-4D92-A206-7BDBD5DD6859Q37047470-8BAE544D-4C01-468C-93A9-C3718AC05FA4Q37335850-80B1BD5B-AF5D-4470-A1AF-307323CDAF5AQ37586232-EE7660B6-86DF-4AD6-85AD-AE9C8CF599F4Q37589663-DC37348B-354D-46C2-9974-317E4A1E780EQ37711628-EC0C3733-F049-47CC-BB0D-1AF8A40EB6A2Q37990767-F3403523-3717-4336-9862-B13D6EBB3E43Q38288742-F41B9D98-A307-4E79-A192-FD66C5BDA707Q38289147-DC77699A-1975-487E-A932-401C8FBBBE42Q38290965-FAEDB9B0-E81B-4820-90FD-2E6CBA8ED62CQ38293432-BF234853-1910-4973-A596-BFD6164C20FFQ38302571-4BC133A9-A082-42FB-A1D6-984F61A6D9EFQ38312109-76F3AFF3-39C6-46C8-910A-ECC9C2042511Q38314580-7B520292-5349-41A5-9A60-29F2E03449B5Q38320678-71C077CE-4F62-4AA5-B165-B3643DD805EBQ38326013-C5198BD6-CADD-464F-8721-7E242A81BE7EQ38348387-138C768A-99B0-4961-A8E4-7BB0D7F3D254Q38350614-69003DDD-88C5-4CB2-A2A4-327B2C2F430DQ38353921-94455E0D-D2A6-44CD-90F0-21827FAE002AQ38354910-995C85E3-638E-4C7F-81AA-C785B0B93DD9Q38356062-CA404695-9CC4-4E6A-B07D-0481FD192932Q38356820-9DD0EB0A-4480-4FB7-9FE8-9971393B1260Q38647560-0D08AAD1-0CED-4859-9149-E9EE6C3607AFQ38647595-769D0687-135F-42DE-BDE4-013A04694575Q38647598-3367E227-624D-4BEF-93CC-1DC25639AE61Q38793611-74F27614-081E-4926-A462-8DB184009CF7Q39387837-87C93734-8A47-4669-A7CF-4754D1934A35Q39683706-8D6FDAFE-2430-453D-8F0A-A0CC4068F829Q40203699-52B8D57A-FC98-45E0-BF0A-67074F44FFA0Q40664639-981F4C8A-BFA7-4D61-9F07-FA6D89D5203CQ40851193-62254AC1-CEE7-45B7-B6EA-128B8F562DC0
P2860
Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Anticoagulant activity of hepa ...... y on immobilized antithrombin.
@en
Anticoagulant activity of hepa ...... y on immobilized antithrombin.
@nl
type
label
Anticoagulant activity of hepa ...... y on immobilized antithrombin.
@en
Anticoagulant activity of hepa ...... y on immobilized antithrombin.
@nl
prefLabel
Anticoagulant activity of hepa ...... y on immobilized antithrombin.
@en
Anticoagulant activity of hepa ...... y on immobilized antithrombin.
@nl
P2093
P2860
P1433
P1476
Anticoagulant activity of hepa ...... y on immobilized antithrombin.
@en
P2093
P2860
P356
10.1016/0014-5793(76)80592-3
P407
P50
P577
1976-07-01T00:00:00Z